We are delighted to report Professor Herrling is now officially appointed as NED to the Board. This position had become vacated by Mr Nick Stephens who has now been invited by the Board to take over as Chair.
Prof Herrling, Ph.D. was the head of corporate research at Novartis and the chairman of board of the Novartis Institute for Tropical Diseases, Singapore. Prior to this, he was the head of Global Research of Novartis Pharma. He is also Professor of Drug Discovery Science at the University of Basel, Switzerland and Full Adjunct Professor at the Harold Dorris Neurobiological Institute, Scripps Research Institute, La Jolla, California. He obtained his Ph.D. in 1975 at the University of Zurich and was a post-doctorate fellow at the UCLA Neuropsychiatric Institute.
In addition he is very familiar with the Neuro-Bio approach, having served on our Science Advisory Board for some years.
Neuro-Bio welcomes Professor Herrling at this formative time in the companies evolution.